ESPOSITO, Carla
 Distribuzione geografica
Continente #
NA - Nord America 6.293
AS - Asia 3.780
EU - Europa 2.021
SA - Sud America 263
AF - Africa 25
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.388
Nazione #
US - Stati Uniti d'America 6.205
HK - Hong Kong 2.162
CN - Cina 631
IT - Italia 507
SG - Singapore 502
UA - Ucraina 493
DE - Germania 262
VN - Vietnam 243
BR - Brasile 240
RU - Federazione Russa 218
FI - Finlandia 156
IE - Irlanda 139
TR - Turchia 79
SE - Svezia 75
FR - Francia 48
GB - Regno Unito 45
KR - Corea 45
MX - Messico 41
CA - Canada 36
IN - India 36
PL - Polonia 15
BD - Bangladesh 14
CZ - Repubblica Ceca 13
JP - Giappone 13
ES - Italia 11
ZA - Sudafrica 11
IQ - Iraq 10
AR - Argentina 8
PK - Pakistan 7
AT - Austria 6
IL - Israele 6
LT - Lituania 5
PH - Filippine 5
CL - Cile 4
ID - Indonesia 4
MA - Marocco 4
RS - Serbia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CO - Colombia 3
JO - Giordania 3
NL - Olanda 3
RO - Romania 3
UZ - Uzbekistan 3
VE - Venezuela 3
AO - Angola 2
AU - Australia 2
BG - Bulgaria 2
EC - Ecuador 2
HN - Honduras 2
JM - Giamaica 2
KE - Kenya 2
MY - Malesia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MG - Madagascar 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
RW - Ruanda 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TV - Tuvalu 1
TW - Taiwan 1
TZ - Tanzania 1
VC - Saint Vincent e Grenadine 1
Totale 12.388
Città #
Hong Kong 2.160
Ann Arbor 1.338
Wilmington 691
Chandler 619
Jacksonville 596
Dallas 510
Princeton 393
Houston 263
Ashburn 220
Dong Ket 210
Woodbridge 209
Singapore 182
Munich 139
Dublin 136
Beijing 120
Boardman 111
Nanjing 110
Dearborn 107
Andover 97
Pellezzano 76
Salerno 65
Izmir 62
Mestre 49
Moscow 49
Los Angeles 44
Fairfield 41
Helsinki 41
Redwood City 37
Nanchang 35
Hebei 33
Shenyang 33
Changsha 27
New York 25
São Paulo 25
Tianjin 21
Jiaxing 20
Pune 19
Napoli 16
Sant'agata De' Goti 16
Montreal 15
Warsaw 15
Washington 15
Cuauhtémoc 14
Santa Clara 14
Agropoli 13
Tokyo 13
Brno 12
Ho Chi Minh City 12
Norwalk 12
Phoenix 12
Turku 12
Belo Horizonte 11
Brooklyn 11
Cava 11
Düsseldorf 11
Ottawa 11
San Diego 11
Seattle 11
Stockholm 11
Guangzhou 9
Istanbul 9
Lessolo 9
London 9
Chicago 8
Johannesburg 8
Naples 8
Poplar 8
Potenza 8
Rio de Janeiro 8
Spinea 8
The Dalles 8
Bari 7
Bologna 7
Boston 7
Caserta 7
Council Bluffs 7
Manchester 7
Chennai 6
Jinan 6
Kunming 6
Marsico Nuovo 6
Mexico City 6
Atlanta 5
Charlotte 5
Curitiba 5
Denver 5
Hefei 5
Portici 5
San Francisco 5
Shanghai 5
Springfield 5
Vienna 5
Ankara 4
Belgrade 4
Brasília 4
Cambridge 4
Columbus 4
Dormagen 4
Guarulhos 4
Hanoi 4
Totale 9.446
Nome #
Searching for the protein targets of 4-nonylphenol using a computational approach 694
Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial Caco-2 cells 616
A preliminary study on nonylphenol toxicity in human intestinal epithelial cells 541
The surfactant 4-nonylphenol is cytotoxic for cells of the human gastrointestinal tract. 307
Anti-transglutaminase antibodies in non-coeliac children suffering from infectious diseases. 253
Searching for the protein targets of 4-nonylphenol using a computational approach 236
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease. 221
Analysis of transglutaminase protein substrates by functional proteomics. 201
4-Nonylphenol reduces cell viability and induces apoptosis and ER-stress in a human epithelial intestinal cell line 174
Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease 162
An acetic acid-based extraction method to obtain high quality collagen from archeological bone remains 162
Anti-tissue transglutaminase antibodies activate intracellular tissue transglutaminase by modulating cytosolic Ca(2+) homeostasis 159
Celiac anti-tissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 by epithelial cells 158
Celiac anti‑type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects 158
Application of a computational approach to identify protein targets for 4-nonylphenol 148
Antibodies against type 2 transglutaminase modulate actin rearrangements and cell cycle in several cell lines 146
The toxic alpha-gliadin peptide 31-43 enters cells without a surface membrane receptor 143
Enzymatic Strategies to Detoxify Gluten:Implications for Celiac Disease 133
Celiac autoantibodies to tissue transglutaminase modulate alpha-gliadin peptide uptake by epithelial cells 133
THE A-GLIADIN PEPTIDE 31-43 INDUCES NF-kB ACTIVATION AND MODULATE TYPE 2 TRANSGLUTAMINASE ACTIVITY IN AN INTESTINAL EPITHELIAL CELL LINE 133
Celiac Disease-Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics 133
Chronic Exposure to Cadmium Disrupts the Adrenal Gland Activity of the Newt Triturus carnifex (Amphibia, Urodela) 131
Autoantibodies to tissue transglutaminase can induce ER (endoplasmic reticulum) stress response in Caco-2 cells 130
Gliadin Peptides Induce Tissue Transglutaminase Activation and ER-Stress through Ca(2+) Mobilization in Caco-2 Cells. 129
Interaction of 'toxic' and 'immunogenic' A-gliadin peptides with a membrane-mimetic environment 128
ANTI-TISSUE TRANSGLUTAMINASE ANTIBODIES ACTIVATE CYTOSOLIC TISSUE TRANSGLUTAMINASE BY MOBILIZING CALCIUM IONS FROM INTRACELLULAR STORES 125
Tissue transglutaminase in celiac disease: role of autoantibodies. 124
Synthesis of peptidocalix[4]arene diversomers as transglutaminase inhibitors by protein surface recognition 124
Identification of differential phosphorylated proteins in Caco-2 cells treated with anti-tissue transglutaminase antibodies 122
A-gliadin peptide 31-43 induces NF-κB and tissue transglutaminase activation in an intestinal epithelial cell line 120
Anti-Tissue Transglutaminase Antibodies from Coeliac Patients Inhibit Transglutaminase Activity both in Vitro and in Situ 119
Biochemical characterization of recombinant rat prostate transglutaminase expressed into MDCK cells 118
Anti-tissue transglutaminase antibodies have biological effects on cultured intestinal biopsies from celiac patients 112
Serum IgA and IgG and intestinal monoclonal anti-tissue transglutaminase antibodies from coeliac patients inhibit the catalytic activity both in vitro and in situ. 111
Caratterizzazione della transglutaminasi da prostata di ratto espressa in cellule MDCK 109
New therapeutic strategies for coeliac disease: tissue transglutaminase as a target 109
Subcellular distribution of type 2 transglutaminase is constitutively different in skin derived-fibroblasts from celiac disease patients and from healthy controls 108
Internalization of alpha gliadin peptide 31-43 by Caco-2 cells does not require a surface receptor. 107
A-GLIADIN PEPTIDES INDUCE TISSUE TRANSGLUTAMINASE ACTIVATION THROUGH CA2+ MOBILIZATION IN CACO-2 CELLS 107
Histological changes, apoptosis and metallothionein levels in Triturus carnifex (Amphibia, Urodela) exposed to environmental cadmium concentrations 106
Mammalian Transglutaminases. Identification of substrates as a key to physiological function and physiopathological relevance. 105
N-terminus end of rat prostate transglutaminase is responsible for its catalytic activity and GTP binding 105
Expression and enzymatic activity of small intestinal tissue transglutaminase in coeliac disease 104
Tissue transglutaminase autoantibodies regulate actin rearrangements and cell cycle in several cell types 103
RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies. 103
Constitutive differential features of type 2 transglutaminase in cells derived from celiac patients and from healthy subjects 100
null 98
Transglutaminase 2 in celiac diasease: Minireview article 98
Celiac anti-tissue transglutaminase antibodies derange alpha gliadin peptide 31-43 uptake by epithelial cells. 98
Proteomics identification of acyl-acceptor and acyl-donor substrates for transglutaminase in a human intestinal epithelial cell line: implications for coeliac disease. 97
Tissue Transglutaminase and Coeliac Disease. 97
Celiac anti-tissue transglutaminase autoantibodies interfere with the ability of alpha-gliadin peptide 31-43 to drive intestinal epithelial cells into S-phase. 94
Transglutaminase surface recognition by peptidocalix[4]arene diversomers. 93
Seminal Vesicle Protein IV and Its Derived Active Peptides: A Possible Physiological Role in Seminal Clotting. 93
Type 2 transglutaminase contributes to define a cellular phenotype typical of celiac cells. 93
GTPase and transglutaminase are associated in the secretion of rat anterior prostate. 91
Studi di specificità di isoforme dell'enzima transglutaminasi per modificare proteine del latte 91
The monoclonal anti-tissue transglutaminase antibody CUB 7402 reduces the alpha-gliadin peptides uptake by Caco-2 cells 91
Structural characterization of transglutaminase-catalyzed cross-linking between glyceraldehyde 3-phosphate deydrogenase and polyglutamine repeat. 90
Expression and Enzymatic Activity of Small Intestinal Tissue Transglutaminase in Coeliac Disease 89
Tissue transglutaminase modulators regulate actin rearrangements and cell cycle in several cell types 85
Tissue transglutaminase is implicated in the antiproliferative and proapoptotic effect induced by the histone deacetylase inhibitor 85
Non celiac patients’ anti-tissue transglutaminase antibodies: immunological and functional characterization. 84
Identification of acyl-acceptor and acyl-donor substrates for transglutaminase in CaCo-2 intestinal cell line: implications for coeliac disease 83
The Pituitary-adrenal gland Activity of Triturus carnifex (Amphibia, Urodela) exposed to Environmental Cadmium Concentrations 83
Interplay between type 2 transglutaminase (Tg2), gliadin peptide 31-43 and anti-tg2 antibodies in celiac disease 83
Studio del riconoscimento tra transglutaminasi di tipo 2 e auto-anticorpi anti-transglutaminasi caratteristici della malattia celiaca 82
Influenza delle modifiche post-traduzionali sulle proprietà biologiche della TGasi presente nel secreto della ghiandola coagulatoria 81
Serum immunoglobulin A and G and monoclonal antibodies anti tissue-transglutaminase from coeliac patients inhibit the catalytic activity both in vitro and in situ. 80
Effects of Methyl Bromide on activity of blood coagulation enzymes 79
Riconoscimento di superficie delle transglutamminasi mediante diversomeri peptidocalix[4]arenici 78
Implication of cell-surface transglutaminase in gliadin peptides uptake by Caco-2 cells 78
Transglutaminase-mediated amine incorporation into substance P protects the peptide against proteolysis in vitro. 77
Interaction of “toxic” and “immunogenic” A-gliadin peptides with a membrane-like environment in vitro. 77
Transglutaminase surface recognition by peptidocalix[4]arene diversomers 75
Role of type 2 transglutaminase autoantibodies in phatogenesis of celiac disease 74
Transglutaminase-synthesized spermine derivative of substance P recognizes rat portal vein neurokinin-3 receptors. 74
Substance P and its transglutaminase-synthesized spermine derivative elicit yawning behavior via nitric oxide in rats. 73
Characterisation of rat coagulating gland transglutaminase expressed in heterologous cell systems 73
Transglutaminase-synthesized analogs of substance P is a selective tool for neurokinin-2 receptors. 72
Studies on transglutaminase type IV in relation to proteins occuring in rat coagulating gland secretion 72
null 71
Ubiquitination of tissue transglutaminase is modulated by interferon alpha in human lung cancer cells 71
Rat coagulating gland secretion contains a kinesin heavy chain-like protein acting as type IV transglutaminase substrate 71
Do tissue transglutaminase antibodies contribute to the intestinal lesion in celiac disease? 71
Tissue transglutaminase autoantibodies regulate actin rearrangements and cell cycle in several cell types. 70
Identification of tissue transglutaminase-reactive lysine residues in glyceraldheide-3-phosphate dehydrogenase 67
Implication of tissue transglutaminase and desmoplakin in cell adhesion mechanism in human epidermis 67
Enzymatic synthesis of vasoactive intestinal peptide analogs by transglutaminase. 67
null 67
Desmoplakin acts as transglutaminase substrate in vitro. 66
Transglutaminase-mediated polyamination of vasoactive intestinal peptide (VIP) Gln16 residue modulates the VIP/PACAP receptor activity. 65
Overlapping between fluorescence modifications and activation of prostate transglutaminase induced by sodium dodecylsulphate. 65
The mechanism of cytotoxicity of 4-nonylphenol in a human hepatic cell line involves ER-stress, apoptosis, and mitochondrial dysfunction 65
IgA e IgG sieriche e anticorpi monoclonali intestinali anti-transglutaminasi tissutale ottenuti da pazienti celiaci inibiscono l'attività catalitica sia in vitro che in situ 64
Protein SV-IV promotes nitric oxide production not associated with apoptosis in murine macrophages. 63
Expression and enzymatic activity of transglutaminase in the normal and coeliac small intestinal mucosa 63
Espressione e attività enzimatica della transglutaminasi tissutale nella mucosa intestinale di pazienti celiaci 62
Structural characterisation of transglutaminase-catalysed protein aggregates correlated to neurodegenerative disorders. 61
Coeliac disease and extraintestinal autoimmunity. 58
Totale 12.085
Categoria #
all - tutte 39.451
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.451


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021772 0 0 0 0 132 37 112 9 132 13 115 222
2021/2022769 0 0 4 2 40 13 1 25 114 87 121 362
2022/20231.343 134 103 31 176 186 260 0 166 196 0 64 27
2023/2024465 48 68 33 21 38 81 23 31 0 26 19 77
2024/20251.308 62 27 54 88 58 147 268 146 183 33 112 130
2025/20263.406 540 980 1.501 330 55 0 0 0 0 0 0 0
Totale 12.598